ClinicalTrials.govpublic full text
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
diffuse midline glioma (dmg), glioblastoma, recurrent ependymoma, recurrent malignant central nervous system neoplasm, spinal cord glioma, world health organization (who) grade iii glioma, cns tumor, central nervous system tumor, h3 k27m-mutant, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1032721
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.